Cases & Deals

  • Home
  • Practices
  • Astellas sells U.S. manufacturing subsidiary to Avara

Share

Astellas sells U.S. manufacturing subsidiary to Avara

August 2016

Client(s) Astellas Pharma Inc.

Jones Day advised Astellas Pharma Inc. in the transfer of its wholly owned manufacturing subsidiary Astellas Pharma Technologies, Inc. to Avara Norman Pharmaceutical Services, Inc. Astellas Pharma Technologies, Inc. will be renamed Avara Pharmaceutical Technologies, Inc.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.